HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC Book Value per Share

The Book Value per Share of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 2, 2026 is 11,366.86 VND. In the previous year, Book Value per Share was 11,463.20 VND — a change of -0.84% (lower).

Book Value per Share

11,366.86VND

YoY

-0.84%

Last updated:

Book Value per Share of HaTay Pharmaceutical JSC is 2024 11,366.86 VND. Book Value per Share of HaTay Pharmaceutical JSC was 2023 11,463.20 VND. It decreases by -0.84% lower compared to the previous year.

The HaTay Pharmaceutical JSC Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2017
2,517.06 VND
Jan 1, 2018
2,758.49 VND
Jan 1, 2019
3,187.81 VND
Jan 1, 2020
3,601.76 VND
Jan 1, 2021
8,057.08 VND
Jan 1, 2022
8,538.19 VND
Jan 1, 2023
11,463.20 VND
Jan 1, 2024
11,366.86 VND
The HaTay Pharmaceutical JSC Book Value per Share history
YEARBook Value per ShareYoY
11,366.86VND-0.84%
11,463.20VND+34.26%
8,538.19VND+5.97%
8,057.08VND+123.70%
3,601.76VND+12.99%
3,187.81VND+15.56%
2,758.49VND+9.59%
2,517.06VND+29.32%
1,946.40VND+22.63%
1,587.26VND+9.50%
1,449.59VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Book Value per Share of HaTay Pharmaceutical JSC is 11,366.86 VND in 2024.

Book Value per Share of HaTay Pharmaceutical JSC changed from 11,463.20 VND to 11,366.86 VND, representing a -0.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — HaTay Pharmaceutical JSC

All Key Metrics — HaTay Pharmaceutical JSC